182 related articles for article (PubMed ID: 38019470)
1. Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets.
Yang Y; Li H; Zheng D; Li X; Liu H
Aging (Albany NY); 2023 Nov; 15(22):13345-13367. PubMed ID: 38019470
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
[TBL] [Abstract][Full Text] [Related]
3. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.
Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH
Front Immunol; 2022; 13():999849. PubMed ID: 36211401
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
5. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
6. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
8. Verification of genetic differences and immune cell infiltration subtypes in the neuroblastoma tumour microenvironment during immunotherapy.
Qian B; Sun J; Zuo P; Da M; Mo X; Fang Y
World J Surg Oncol; 2022 May; 20(1):169. PubMed ID: 35643506
[TBL] [Abstract][Full Text] [Related]
9. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
10. An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer.
Xiao Z; Cai Z; Deng D; Tong S; Zu X
Front Immunol; 2022; 13():1000321. PubMed ID: 36211349
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients.
Wang X; Zeng W; Yang L; Chang T; Zeng J
Cancer Genet; 2023 Jun; 274-275():41-50. PubMed ID: 36972656
[TBL] [Abstract][Full Text] [Related]
12. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and their correlation with infiltration of immune cells in
Chen J; Sun M; Chen C; Jiang B; Fang Y
Front Immunol; 2022; 13():1016683. PubMed ID: 36311753
[TBL] [Abstract][Full Text] [Related]
14. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis.
Fetahu IS; Esser-Skala W; Dnyansagar R; Sindelar S; Rifatbegovic F; Bileck A; Skos L; Bozsaky E; Lazic D; Shaw L; Tötzl M; Tarlungeanu D; Bernkopf M; Rados M; Weninger W; Tomazou EM; Bock C; Gerner C; Ladenstein R; Farlik M; Fortelny N; Taschner-Mandl S
Nat Commun; 2023 Jun; 14(1):3620. PubMed ID: 37365178
[TBL] [Abstract][Full Text] [Related]
16. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
19. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer.
Lu S; Hua J; Liu J; Wei M; Liang C; Meng Q; Zhang B; Yu X; Wang W; Xu J
BMC Cancer; 2022 Jul; 22(1):804. PubMed ID: 35864471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
